Found 46 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is K and Author is Kolluri, Siva Kumar  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
A. K. Ehrlich, Pennington, J. M., Wang, X., Rohlman, D., Punj, S., Löhr, C. V., Newman, M. T., Kolluri, S., and Kerkvliet, N. I., Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice., J Immunol, vol. 196, no. 1, pp. 264-73, 2016.
A. K. Ehrlich, Pennington, J. M., Tilton, S., Wang, X., Marshall, N. B., Rohlman, D., Funatake, C., Punj, S., O'Donnell, E. F., Yu, Z., Kolluri, S., and Kerkvliet, N. I., AhR activation increases IL-2 production by alloreactive CD4 T cells initiating the differentiation of mucosal-homing Tim3 Lag3 Tr1 cells., Eur J Immunol, vol. 47, no. 11, pp. 1989-2001, 2017.
S. Sengupta, Bisson, W. H., Mathew, L. K., Kolluri, S., and Tanguay, R. L., Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration model, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, vol. 156, no. 2, pp. 121 - 129, 2012.
D. C. Koch, Jang, H. S., O'Donnell, E. F., Punj, S., Kopparapu, P. R., Bisson, W. H., Kerkvliet, N. I., and Kolluri, S., Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1., Oncogene, 2015.
E. F. O'Donnell, Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor, PLoS ONE, vol. 5, no. 10, p. e13128, 2010.
E. F. O'Donnell, Saili, K. S., Koch, D. C., Kopparapu, P. R., Farrer, D., Bisson, W. H., Mathew, L. K., Sengupta, S., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S. Kumar, The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor., PLoS One, vol. 5, no. 10, 2010.
M. I. Dawson, Hobbs, P. D., Peterson, V. J., Leid, M., Lange, C. W., Feng, K. - C., Chen, G. -quan, Gu, J., Li, H., Kolluri, S., and , Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity, Cancer research, vol. 61, pp. 4723–4730, 2001.
E. F. O'Donnell, Jang, H. Sang, Pearce, M. C., Kerkvliet, N. I., and Kolluri, S., The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells., Oncotarget, vol. 8, no. 15, pp. 25211-25225, 2017.
E. F. ’ Donnell, Kopparapu, P. Rao, Koch, D. C., Jang, H. Sang, Phillips, J. Lynne, Tanguay, R. L., Kerkvliet, N. I., and Kolluri, S., The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells, PLoS ONE, vol. 7, no. 7, p. e40926, 2012.
E. F. O'Donnell, Kopparapu, P. Rao, Koch, D. C., Jang, H. Sang, Phillips, J. Lynne, Tanguay, R. L., Kerkvliet, N. I., and Kolluri, S. Kumar, The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells., PLoS One, vol. 7, no. 7, p. e40926, 2012.
E. F. O'Donnell, Koch, D. C., Bisson, W. H., Jang, H. S., and Kolluri, S., The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells, Cell death & disease, vol. 5, p. e1038, 2014.
I
K. J. Smith, Murray, I. A., Tanos, R., Tellew, J., Boitano, A. E., Bisson, W. H., Kolluri, S., Cooke, M. P., and Perdew, G. H., Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism, Journal of Pharmacology and Experimental Therapeutics, vol. 338, pp. 318–327, 2011.
H. Jang, Pearce, M. C., O'Donnell, E. F., Nguyen, B., Truong, L., Mueller, M. J., Bisson, W. H., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells, Biology (Basel), vol. 6, no. 4, 2017.
H. Sang Jang, Pearce, M. C., O'Donnell, E. F., Nguyen, B. Duc, Truong, L., Mueller, M. J., Bisson, W. H., Kerkvliet, N. I., Tanguay, R. L., and Kolluri, S., Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells., Biology (Basel), vol. 6, no. 4, 2017.
E. Morgan, Gamble, J. T., Pearce, M. C., Elson, D. J., Tanguay, R. L., Kolluri, S. Kumar, and Reich, Norbert O, Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery., Apoptosis, 2019.
M. C. Pearce, Gamble, J. T., Kopparapu, P. R., O'Donnell, E. F., Mueller, M. J., Jang, H. Sang, Greenwood, J. A., Satterthwait, A. C., Tanguay, R. L., Zhang, X. -kun, and Kolluri, S., Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells., Oncotarget, vol. 9, no. 40, pp. 26072-26085, 2018.

Pages